首页> 外国专利> Combination Therapy with interferon alpha ribarvirina to eradicate HCV RNA detectable in patients with chronic hepatitis C infection

Combination Therapy with interferon alpha ribarvirina to eradicate HCV RNA detectable in patients with chronic hepatitis C infection

机译:慢性丙型肝炎患者联合治疗与干扰素α核糖核酸消除根源可检测到的HCV RNA

摘要

A method for treating a patient suffering from a chronic hepatitis C infection, to eradicate HCV RNA detectable, which comprises a combination TherapyWhich employs a therapeutically effective amount of Ribavirin Derivative of the formula I and a therapeutically effective amount of interferon alpha,During a period that varies between 20 and 80 Weeks.
机译:一种治疗慢性丙型肝炎患者以根除可检测到的HCV RNA的方法,该方法包括在治疗期间使用治疗有效量的式I利巴韦林衍生物和治疗有效量的干扰素α的组合在20到80周之间变化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号